Fig. 5From: m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinomaHeatmap shows the relevance of the m6A signature gene expression and clinical outcome across various cancer types using the Cox proportional hazard model. The increased risk is marked in red, and the decreased risk is marked in blueBack to article page